SEC Form 4 · accession 0001588365-26-000007
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ezio Bonvini
Officer — Sr VP, Research & CSO
Period of report
Aug 17, 2026
Accepted (ET)
Aug 18, 2026 · 4:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2026 | M | 40,000 | $2.60 | A | 185,799 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $2.60 | Aug 17, 2026 | M | 40,000 | D | — | Feb 7, 2035 | Common Stock | 40,000 | 88,000 | D |
Explanation of responses
- F1The transaction represents an exercise and hold of options.
- F212.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.